J Korean Pediatr Soc.  2002 Dec;45(12):1585-1590.

A Case of Rhizomelic Chondrodysplasia Punctata Type I

Affiliations
  • 1Department of Pediatrics, College of Medicine, Inha University, Incheon, Korea. ysped@inha.ac.kr
  • 2Seoul Clinical Laboratory, Seoul, Korea.

Abstract

Rhizomelic chondrodysplasia punctata(RCDP) is a rare autosomal recessive disorder clinically characterized by symmetrical shortening of the proximal limbs, contractures of joints, a typical dysmorphic face, cataracts, and itchyosis. Patients with RCDP can be subdivided into three subgroups based on biochemical analysis and complementation studies. RCDP type I results from mutations in the PEX7 gene encoding the peroxisomal targeting signal type II(PST2) receptors and presents with both a defect in plasmalogen biosynthesis and phytanic acid oxidation. RCDP type II is deficient in the activity of dihydroxyacetonephosphate acyltransferase(DHAP-AT). RCDP type III is deficient in alkyl-dihydroxyacetonephosphate synthase(alkyl-DHAP). We report a case of RCDP type I which was confirmed with biochemical study, fibroblast culture, and gene study.

Keyword

Rhizomelic chondrosdysplasia punctata; Biochemical study; Fibroblast; Gene

MeSH Terms

Cataract
Chondrodysplasia Punctata, Rhizomelic*
Complement System Proteins
Contracture
Extremities
Fibroblasts
Humans
Joints
Phytanic Acid
Complement System Proteins
Phytanic Acid
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr